🏢 官网IRTEMDoubao · 实盘不做把握 9/10不做原因:无增量信息
北京时间·🕒 发布 04:01:00(美东 10-15 16:01)·⟳ 抓取 04:05:30回填·⚡ 决策 10-16 04:06:19·11.7 天前
Tempus AI（TEM）仅宣布将于11月2日盘前发布三季报，未含任何业绩数字或指引
这是一条纯程序性的财报日期公告（earnings date announcement），全文只确定发布时间与电话会接入方式，没有任何业绩数字、指引、订单或经营更新，缺乏预期差与可交易方向。
📄 原文TEM↗ 原文
Tempus to Report Third Quarter 2026 Financial Results on November 2
CHICAGO --(BUSINESS WIRE)--Oct. 15, 2026-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of…
不做 Tempus AI, Inc.（TEM.US）
纯财报日期预告，不含任何业绩、指引或经营增量，无预期差与可交易方向；等待11月2日盘前实际财报发布后再研判。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Tempus AI仅预告11月2日盘前发财报，无任何业绩或指引信息，属中性的日历性事件，不产生edge，故不做；待11月2日实际财报再研判。
关键理由
- 无：当前事件不含任何可形成多空方向的财务或经营增量。
主要风险
- 真正的波动来自11月2日财报的实际数据与指引，而非本条日期通知；提前基于此条布局等于无信息赌博。
先例如何影响了这次决策
对本次决策的影响:确认本条不交易；把交易窗口推迟到11月2日实际财报。
方向:无可对照先例，且财报日期通知本身属程序性事件，不产生方向性收益分布，无需用先例校准。
涨幅量级:无预期差，不设定止盈/止损幅度。
形态:不适用
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 11 ms
{"result": "search_processed_events:agent query=`tem q3 2026 earnings date announcement november 2 | tempus ai third quarter 2026 financial results november 2 conference call`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前事件继续正常研判。"}
原文全文
展开原文 · 1,893 字
CHICAGO
--(BUSINESS WIRE)--Oct. 15, 2026--
Tempus AI, Inc.
(NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it will report financial results for the third quarter ended
September 30, 2026
, before
U.S
. markets open on
Monday, November 2, 2026
.
The company will host a conference call and live audio webcast at 8:45 a.m ET to discuss the results and provide a business update. The call will be led by Tempus Founder and CEO,
Eric Lefkofsky
, and Chief Financial Officer,
Jim Rogers
.
The live audio webcast will be accessible through the “Events” section of the
Tempus Investor Relations website
or directly via the
webcast link
. Alternatively, the call can be accessed via the following:
Conference ID:
579 261 752
North America
(Toll-Free):
1(833) 461-5787
International (Toll):
+1 (585) 542-9983
For those unable to listen to the live broadcast, a recording will be available on the website following the call.
About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit
www.tempus.com
.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20261015709881/en/
Investors
Elizabeth Krutoholow
Kendra Webster
investorrelations@tempus.com
Media
Kelli Manalli
media@tempus.com
Source: Tempus AI, Inc.
--(BUSINESS WIRE)--Oct. 15, 2026--
Tempus AI, Inc.
(NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it will report financial results for the third quarter ended
September 30, 2026
, before
U.S
. markets open on
Monday, November 2, 2026
.
The company will host a conference call and live audio webcast at 8:45 a.m ET to discuss the results and provide a business update. The call will be led by Tempus Founder and CEO,
Eric Lefkofsky
, and Chief Financial Officer,
Jim Rogers
.
The live audio webcast will be accessible through the “Events” section of the
Tempus Investor Relations website
or directly via the
webcast link
. Alternatively, the call can be accessed via the following:
Conference ID:
579 261 752
North America
(Toll-Free):
1(833) 461-5787
International (Toll):
+1 (585) 542-9983
For those unable to listen to the live broadcast, a recording will be available on the website following the call.
About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit
www.tempus.com
.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20261015709881/en/
Investors
Elizabeth Krutoholow
Kendra Webster
investorrelations@tempus.com
Media
Kelli Manalli
media@tempus.com
Source: Tempus AI, Inc.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
0fbaaa3ca7· 2026-10-16 04:06 · doubao / doubao-seed-evolving-latest-version · 策略包2226518bfdee当前